Correlation Between Visa and Oryzon Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and Oryzon Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Oryzon Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Oryzon Genomics SA, you can compare the effects of market volatilities on Visa and Oryzon Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Oryzon Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Oryzon Genomics.

Diversification Opportunities for Visa and Oryzon Genomics

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Visa and Oryzon is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Oryzon Genomics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oryzon Genomics SA and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Oryzon Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oryzon Genomics SA has no effect on the direction of Visa i.e., Visa and Oryzon Genomics go up and down completely randomly.

Pair Corralation between Visa and Oryzon Genomics

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.73 times more return on investment than Oryzon Genomics. However, Visa Class A is 1.37 times less risky than Oryzon Genomics. It trades about 0.49 of its potential returns per unit of risk. Oryzon Genomics SA is currently generating about -0.16 per unit of risk. If you would invest  31,440  in Visa Class A on November 2, 2024 and sell it today you would earn a total of  2,865  from holding Visa Class A or generate 9.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy86.36%
ValuesDaily Returns

Visa Class A  vs.  Oryzon Genomics SA

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.
Oryzon Genomics SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oryzon Genomics SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Visa and Oryzon Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and Oryzon Genomics

The main advantage of trading using opposite Visa and Oryzon Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Oryzon Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oryzon Genomics will offset losses from the drop in Oryzon Genomics' long position.
The idea behind Visa Class A and Oryzon Genomics SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators